🔎 Trials Near Me

Home › Kanser sa Prostate › Massachusetts

Pag-aaral pangklinika para sa Kanser sa Prostate sa Massachusetts

63 pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa mga site sa Massachusetts.

Mga Lungsod sa Massachusetts

Opisyal na teksto ng pag-aaral (English)

The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)

  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 55 hanggang 69 · Kalalakihan · Na-update Nob 13, 2026 · NCT05926102

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Lahey Clinic, Burlington
  • Lahey Clinic Peabody, Peabody
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03866382

Prostate Cancer Genetic Risk Evaluation and Screening Study

  • Massachusetts General Hospital, Boston
Nagre-recruitObservasyonal na pag-aaral
Edad 35 pataas · Kalalakihan · Na-update Nob 10, 2026 · NCT05129605

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • Massachusetts General Hospital, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06465069

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07114601

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Dana-Farber Cancer Institute, Boston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07059884

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • Dana-Farber Cancer Institute at Foxborough, Foxborough
  • Dana Farber-Merrimack Valley, Methuen
  • Dana-Farber/Brigham and Women's Cancer Center at Milford Regional, Milford
  • at 2 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06632977

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

  • Dana Farber Mass General Brigham Cancer Care Inc, Boston
Nagre-recruitPhase 1/2
Edad 18 pataas · Kalalakihan · Na-update Nob 3, 2026 · NCT06800313

A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer

  • Greater Boston Urology, Plymouth
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Nob 3, 2026 · NCT07832292

A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Nob 2, 2026 · NCT07581184

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • Beth Israel Deaconess Medical Center ( Site 0043), Boston
  • Dana Farber Cancer Institute ( Site 0012), Boston
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 30, 2026 · NCT06925737

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

  • Dana Farber Cancer Institute, Boston
  • Brigham and Womens Hospital, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Okt 29, 2026 · NCT06062745

Precision-Based Genomics in Prostate Cancer

  • Dana Farber Cancer Institute, Boston, MA, Boston
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Kalalakihan · Na-update Okt 26, 2026 · NCT04706663

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
  • Dana-Farber/Brigham and Women's Cancer Center at Milford Regional, Milford
  • at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 23, 2026 · NCT05946213

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

  • Research Site, Boston
Nagre-recruitPhase 1/2
Edad 18 hanggang 130 · Kalalakihan · Na-update Okt 22, 2026 · NCT07181161

Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy

  • Massachsuetts General Hospital, Boston
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Kalalakihan · Na-update Okt 20, 2026 · NCT01961713

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

  • Research Site, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Okt 16, 2026 · NCT06879041

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

  • Massachusetts General Hospital, Boston
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT06239194

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • Beth Israel Deaconess Med Center, Boston
  • Dana Farber Cancer Institute, Boston
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Kalalakihan · Na-update Okt 15, 2026 · NCT06855277

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  • Research Site, Plymouth
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 14, 2026 · NCT06952803

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT05919264

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

  • Research Site, Boston
Nagre-recruitPhase 1/2
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05417594

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial

  • Dana Farber Cancer Institute, Boston
Nagre-recruit
Edad 18 pataas · Kalalakihan · Na-update Set 28, 2026 · NCT06496256

Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes

  • Dana-Farber Cancer Institute, Boston
Nagre-recruit
Edad 18 pataas · Kalalakihan · Na-update Set 25, 2026 · NCT07729150

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

  • Harvard Medical School-Massachusetts General Hospital, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Set 25, 2026 · NCT06801236

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Set 24, 2026 · NCT07719361

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  • Dana Farber Cancer Institute, Boston
  • Beth Israel Deaconess Medical Center, Boston
Nagre-recruitPhase 2/3
Edad 18 hanggang 100 · Kalalakihan · Na-update Set 22, 2026 · NCT06780670

CV CARE: CardioVascular Care in PC Patients

  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Nagre-recruit
Edad 18 pataas · Kalalakihan · Na-update Set 22, 2026 · NCT06202820

Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial

  • Beth Israel Deaconess Medical Center, Boston
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Nagre-recruit
Edad 18 pataas · Kalalakihan · Na-update Set 10, 2026 · NCT06040125

Serial MRI Scans During Radiation Therapy

  • Brigham and Women Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT04188535

Prostate Active Surveillance Study

  • Beth Israel Deaconess Medical Center/Harvard Medical School, Boston
Nagre-recruitObservasyonal na pag-aaral
Edad 21 pataas · Kalalakihan · Na-update Set 2, 2026 · NCT00756665

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

  • Dana Farber Cancer Institute, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Ago 21, 2026 · NCT06844383

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

  • Brigham and Women's Hospital, Boston
Nagre-recruitPhase 2
Edad 40 pataas · Kalalakihan · Na-update Ago 17, 2026 · NCT06957691

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

  • Dana-Farber Cancer Institute / Beth Israel Deaconess Medical Center, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Ago 14, 2026 · NCT04812366

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Ago 10, 2026 · NCT06067841

RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
  • Dana-Farber Cancer Institute at Foxborough, Foxborough
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Hul 30, 2026 · NCT05765500

Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy

  • Dana Farber Cancer Institute, Boston
Nagre-recruit
Edad 18 pataas · Kalalakihan · Na-update Hul 29, 2026 · NCT05327465

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.